Mabylon

Mabylon

Antibody-based therapeutics for allergies, inflammation, and neurological disorders using human B-cell screening.

HQ location
Zurich, Switzerland
Launch date
Employees
Enterprise value
$55—83m
Company register number
CH-020.3.037.422-6
Authorizing premium user...